Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oncogenic regulation of tumor metabolic reprogramming
Míriam Tarrado‐Castellarnau, Pedro de Atauri, Marta Cascante
Oncotarget (2016) Vol. 7, Iss. 38, pp. 62726-62753
Open Access | Times Cited: 138

Showing 1-25 of 138 citing articles:

Lipid metabolism reprogramming and its potential targets in cancer
Chunming Cheng, Feng Geng, Xiang Cheng, et al.
Cancer Communications (2018) Vol. 38, Iss. 1, pp. 1-14
Open Access | Times Cited: 657
Molecular Mechanisms Linking Exercise to Cancer Prevention and Treatment
Pernille Højman, Julie Gehl, Jesper Frank Christensen, et al.
Cell Metabolism (2017) Vol. 27, Iss. 1, pp. 10-21
Open Access | Times Cited: 468
The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer
Dimakatso Alice Senthebane, Arielle Rowe, Nicholas Ekow Thomford, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 7, pp. 1586-1586
Open Access | Times Cited: 367
The dynamic and stress-adaptive signaling hub of 14-3-3: emerging mechanisms of regulation and context-dependent protein–protein interactions
Katie L. Pennington, Chan Ty, Matthew P. Torres, et al.
Oncogene (2018) Vol. 37, Iss. 42, pp. 5587-5604
Open Access | Times Cited: 319
MYC as a target for cancer treatment
Michael J. Duffy, Shane O’Grady, Minhong Tang, et al.
Cancer Treatment Reviews (2021) Vol. 94, pp. 102154-102154
Open Access | Times Cited: 318
Role of NAD+ in regulating cellular and metabolic signaling pathways
Sara Amjad, Sabah Nisar, Ajaz A. Bhat, et al.
Molecular Metabolism (2021) Vol. 49, pp. 101195-101195
Open Access | Times Cited: 207
Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma
Liang Zhang, Yixin Yao, Shaojun Zhang, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 491
Closed Access | Times Cited: 203
NAD Metabolism in Cancer Therapeutics
Keisuke Yaku, Keisuke Okabe, Keisuke Hikosaka, et al.
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 184
Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents
Pierre V. Candelaria, Lai Sum Leoh, Manuel L. Penichet, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 155
Cancer metabolism and carcinogenesis
Jianqiang Yang, Chloe Shay, Nabil F. Saba, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 33
Metabolic Plasticity in Chemotherapy Resistance
María Andrea Desbats, Isabella Giacomini, Tommaso Prayer‐Galetti, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 135
Adapt and conquer: Metabolic flexibility in cancer growth, invasion and evasion
Peter Kreuzaler, Yulia Panina, Joanna Segal, et al.
Molecular Metabolism (2019) Vol. 33, pp. 83-101
Open Access | Times Cited: 133
p53 and glucose metabolism: an orchestra to be directed in cancer therapy
Ana Gomes, Helena Ramos, Joana Soares, et al.
Pharmacological Research (2018) Vol. 131, pp. 75-86
Closed Access | Times Cited: 117
Metabolic Fingerprinting Links Oncogenic PIK3CA with Enhanced Arachidonic Acid-Derived Eicosanoids
Nikos Koundouros, Evdoxia Karali, Aurélien Tripp, et al.
Cell (2020) Vol. 181, Iss. 7, pp. 1596-1611.e27
Open Access | Times Cited: 112
Vacuolar ATPase as a potential therapeutic target and mediator of treatment resistance in cancer
Bradleigh Whitton, Haruko Okamoto, Graham Packham, et al.
Cancer Medicine (2018) Vol. 7, Iss. 8, pp. 3800-3811
Open Access | Times Cited: 105
Metabolic Plasticity of Tumor Cell Mitochondria
Giuseppe Cannino, Francesco Ciscato, Ionica Masgras, et al.
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 86
Mitochondrial metabolism: a predictive biomarker of radiotherapy efficacy and toxicity
Farzad Taghizadeh‐Hesary, Mohammad Houshyari, Mohammad Farhadi
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 9, pp. 6719-6741
Closed Access | Times Cited: 29
Mitochondrial Metabolism: A New Dimension of Personalized Oncology
Babak Behnam, Farzad Taghizadeh‐Hesary
Cancers (2023) Vol. 15, Iss. 16, pp. 4058-4058
Open Access | Times Cited: 25
Tryptophan fuels MYC-dependent liver tumorigenesis through indole 3-pyruvate synthesis
Niranjan Venkateswaran, R. Bayes Garcia, M. Carmen Lafita‐Navarro, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
A prismatic view of the epigenetic-metabolic regulatory axis in breast cancer therapy resistance
Chandrima Das, Apoorva Bhattacharya, Swagata Adhikari, et al.
Oncogene (2024) Vol. 43, Iss. 23, pp. 1727-1741
Open Access | Times Cited: 10
Glucose-6-phosphate dehydrogenase and transketolase modulate breast cancer cell metabolic reprogramming and correlate with poor patient outcome
Adrián Benito, Ibrahim H. Polat, Verónique Noé, et al.
Oncotarget (2017) Vol. 8, Iss. 63, pp. 106693-106706
Open Access | Times Cited: 74
An enolase inhibitor for the targeted treatment of ENO1-deleted cancers
Yu-Hsi Lin, Nikunj Satani, Naima Hammoudi, et al.
Nature Metabolism (2020) Vol. 2, Iss. 12, pp. 1413-1426
Open Access | Times Cited: 66
Signaling Pathways Regulating Redox Balance in Cancer Metabolism
Maria Chiara De Santis, Paolo E. Porporato, Miriam Martini, et al.
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 62
Enzyme-based autophagy in anti-neoplastic management: From molecular mechanisms to clinical therapeutics
Amir Ajoolabady, Ayuob Aghanejad, Yaguang Bi, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1874, Iss. 1, pp. 188366-188366
Closed Access | Times Cited: 50
The evolution of cyclin dependent kinase inhibitors in the treatment of cancer
Komal Jhaveri, Howard A Burris rd, Timothy A. Yap, et al.
Expert Review of Anticancer Therapy (2021) Vol. 21, Iss. 10, pp. 1105-1124
Open Access | Times Cited: 41
Page 1 - Next Page

Scroll to top